Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRR | Q9GZT4 | 2/20 | 0.61 |
| ▸ | PPARG | P37231 | 17/20 | 0.53 |
| ▸ | PPARA | Q07869 | 15/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7299501 | 0.93 | SRR (0.57) | SRRPPARGPPARAACE | |
| SCHEMBL7299495 | 0.93 | SRR (0.57) | SRRPPARGPPARAACE | |
| SCHEMBL24328381 | 0.88 | SLC7A5 (0.49) | SRRPPARGPPARA | |
| Hydrochloric Acid SCHEMBL7302958 | 0.88 | SRR (0.54) | SRRPPARGPPARAACE | |
| SCHEMBL24328380 | 0.87 | PPARG (0.57) | SRRPPARGPPARA | |
| SCHEMBL6590735 | 0.82 | PPARG (0.66) | PPARGPPARA | |
| SCHEMBL3430510 | 0.80 | SRR (0.50) | SRRPPARGPPARA | |
| SCHEMBL24301971 | 0.78 | SMN1; SMN2 (0.66) | ACE | |
| SCHEMBL13311342 | 0.78 | SRR (0.48) | SRRPPARGPPARA | |
| SCHEMBL6487486 | 0.78 | SRR (0.48) | SRRPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399297-A1 | Novel Glutamine Analogs | JACOBIO PHARMACEUTICALS CO., LTD (CN) | 2023-12-14 | — | — | US | disclosed |
| US-20230399297-A1 | Novel Glutamine Analogs | JACOBIO PHARMACEUTICALS CO., LTD (CN) | 2023-12-14 | — | — | US | disclosed |
| WO-2022078416-A1 | NOVEL GLUTAMINE ANALOGS | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2022-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399297-A1 | Novel Glutamine Analogs | GLUL, GATD3, GLS | SRR 3147/4885PPARG 1211/4885PPARA 1857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.